N/A
N=22
Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea
Hypercapnia
Bottom Line
View on ClinicalTrials.gov: NCT00708526 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Oct 2011
Primary outcome: Primary: Recovery From Anesthesia — 53.0; 62.9 minutes — p=>0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- standard of care for phase one anesthesia care (Other); Quick Emergence Device (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Utah
- Primary completion
- Nov 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recovery From Anesthesia |
53.0; 62.9 | >0.05 |
| SECONDARY Return of Cognitive Function |
10.9; 18.2 | 0.039 sig |
Summary
The proposed study will measure the time from the end of surgery until the time patients meet the discharge criteria from the postoperative anesthesia care unit and the time from the end of surgery until the patients regained cognitive function after anesthesia.
Eligibility Criteria
Inclusion Criteria
- adults
- ASA class I-III
- both genders
- scheduled to undergo eye surgery at the Moran Hospital.
Exclusion Criteria
- a history of renal or hepatic disease,
- chronic alcohol or drug abuse,
- disabling neuropsychiatric disorder,
- hypersensitivity or unusual response to other halogenated anesthetics,
- pulmonary hypertension,
- increased intracranial pressure,
- seizure disorder
- personal/familial history of malignant hyperthermia.
- currently being treated with known hepatic enzyme-inducing drugs (e.g., phenobarbital, dilantin or isoniazid)
- or with drugs known to alter anesthetic requirements (e.g., opiates, clonidine, alpha2 agonists, alcohol, anticonvulsants, antidepressants, barbiturates, benzodiazepines or other tranquilizers).
- intolerance to non-steroidal anti-inflammatories.
- have received general anesthesia within the previous 7 days,
- received any investigational drug within the previous 28 days,
- participated in a previous isoflurane or desflurane study
- Female subjects can be neither pregnant nor breast feeding.
Data sourced from ClinicalTrials.gov (NCT00708526). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.